[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-390505-105":59,"doc-detail-390505-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","kdoqi-clinical-practice-guideline-hemodialysis-update-public-review-draft-2015","KDOQI Clinical Practice Guideline Hemodialysis Update - Public Review Draft 2015","","KDOQI updates the Clinical Practice Guideline for Hemodialysis Adequacy, presenting a public review draft dated 2015. The document explains intended use of the guideline for decision support while clarifying it is not a standard of care and allows appropriate practice variation. It includes disclosure requirements for work group conflicts of interest, notes the guideline is not final, and provides a structured table of contents covering guideline statements, rating descriptions, CKD nomenclature, abbreviations, executive summary, and five hemodialysis guideline areas.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/kdoqi-clinical-practice-guideline-hemodialysis-update-public-review-draft-2015/390505/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/kdoqi-clinical-practice-guideline-hemodialysis-update-public-review-draft-2015/390505.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-25",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of this KDOQI hemodialysis adequacy guideline update?","Question",{"text":113,"@type":114},"It is designed to provide information and assist decision making. It is not intended to define a standard of care or prescribe an exclusive course of management.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the document address conflicts of interest?",{"text":118,"@type":114},"Kidney Disease Outcomes Quality Initiative requires each work group member to complete, sign, and submit a disclosure and attestation form covering relationships that may create perceived or actual conflicts.",{"name":120,"@type":111,"acceptedAnswer":121},"Is this 2015 KDOQI guideline update final and can it be quoted?",{"text":122,"@type":114},"The document states that NKF KDOQI Clinical Practice Guideline for Hemodialysis Adequacy, Update 2015 is not final. It also requests that no part of the document be quoted or reproduced.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},390505,1790624609,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","KDOQI Clinical Practice Guideline Hemodialysis Update  \nUpdate of the KDOQI™ Clinical Practice Guideline for Hemodialysis Adequacy  \nRunning head: Hemodialysis Guideline Update  \nPUBLIC REVIEW DRAFT 2015  \nCONFIDENTIAL: PLEASE DO NOT DISTRIBUTE  \nDISCLAIMER  \nSECTION I: USE OF THE CLINICAL PRACTICE GUIDELINE  \nThis Clinical Practice Guideline document is based upon the best information available as of \u003C\u003CTBD>> . It is designed to provide information and assist decision making. It is not intended to define a standard of care, and should not be construed as one, nor should it be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health-care professional making use of these recommendations is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.  \nSECTION II: DISCLOSURE  \nKidney Disease Outcomes Quality Initiative™ (KDOQI) makes every effort to avoid any actual or reasonably perceived conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the Work Group. All members of the Work Group are required to complete, sign, and submit a disclosure and attestation form showing all such relationships that might be perceived or actual conflicts of interest. This document is updated annually and information is adjusted accordingly. All reported information will be printed in the final publication and are on file at the National Kidney Foundation (NKF) .  \nNOTE:  \nNKF KDOQI Clinical Practice Guideline for Hemodialysis Adequacy, Update 2015 is not final.  \nPlease do not quote or reproduce any part of this document.  \nTABLE OF CONTENTS  \nDisclaimer…………………………………………………………………………………………………………. ii  \nWork Group Membership…………………………………………………………………………………………. iv  \nCurrent CKD Nomenclature Used by KDOQI……………………………………………………………………. vii  \nAbbreviations and Acronyms……………………………………………………………………………………... 8  \nExecutive Summary………………………………………………………………………………....................... 10  \nGuideline Statements and Description for Rating Guideline Recommendations …………………..................... 13  \nGuideline 1: Timing of Hemodialysis Initiation…………………………………………………………………. 20  \nGuideline 2: Frequent and Long Duration Hemodialysis………………………………………………………… 35  \nGuideline 3: Measurement of Dialysis: Urea Kinetics.………………………………………………………….. 52  \nGuideline 4: Volume and Blood Pressure Control: Treatment Time and Ultrafiltration Rate………………….. 63  \nGuideline 5: Hemodialysis Membranes…………………………………………………………………………. 72  \nWork Group Biographic and Disclosure Information…………………………………………………………….. 76  \nKDOQI  \nClinical Practice Guideline Hemodialysis Update  \nWork Group Chairs  \nJohn Daugirdas, MD  \nClinical Professor of Medicine University of Illinois College of Medicine 15 W 560 89 Street  \nBurr Ridge, IL 60527  \n630-325-3276 Fax: 630-887-1446  \n[j](jtdaugir@uic.edu)[tdaugir@uic.edu](jtdaugir@uic.edu)  \nThomas A. Depner, MD  \nProfessor of Medicine University of California, Davis 4150 V Street, Suite 3500 Sacramento, CA 95817-1460 916-734-3774 Fax 916-734-7920 [tadepner@ucdavis.edu](tadepner@ucdavis.edu)  \nWork Group  \nJula Inrig, MD, MHS, FASN  \nGlobal Medical Director and Therapeutic Strategy Lead in Nephrology Therapeutic Science and Strategy Unit, Quintiles  \nAdjunct Associate in Medicine, Division of Nephrology, Duke University and Duke Clinical Research Institute  \n20205 Chandler Drive Yorba Linda, CA 92887.  \n214-505-6781 Fax 919-800-0095  \n[j](jula.inrig@quintiles.com)[ula.inrig@quintiles.com](jula.inrig@quintiles.com)  \nRajnish Mehrotra, MD, FASN  \nProfessor of Medicine, Division of Nephrology Section C","cbCaistEJflHi63t","https://ap.wps.com/l/cbCaistEJflHi63t","pdf",651779,78,"English","# Disclaimer\n# Disclosure\n# Work Group Membership\n# Current CKD Nomenclature Used by KDOQI\n# Abbreviations and Acronyms\n# Executive Summary\n# Guideline Statements and Description for Rating Guideline Recommendations\n# Guideline 1: Timing of Hemodialysis Initiation\n# Guideline 2: Frequent and Long Duration Hemodialysis\n# Guideline 3: Measurement of Dialysis: Urea Kinetics\n# Guideline 4: Volume and Blood Pressure Control: Treatment Time and Ultrafiltration Rate\n# Guideline 5: Hemodialysis Membranes\n# Work Group Biographic and Disclosure Information","[{\"question\":\"What is the purpose of this KDOQI hemodialysis adequacy guideline update?\",\"answer\":\"It is designed to provide information and assist decision making. It is not intended to define a standard of care or prescribe an exclusive course of management.\"},{\"question\":\"How does the document address conflicts of interest?\",\"answer\":\"Kidney Disease Outcomes Quality Initiative requires each work group member to complete, sign, and submit a disclosure and attestation form covering relationships that may create perceived or actual conflicts.\"},{\"question\":\"Is this 2015 KDOQI guideline update final and can it be quoted?\",\"answer\":\"The document states that NKF KDOQI Clinical Practice Guideline for Hemodialysis Adequacy, Update 2015 is not final. It also requests that no part of the document be quoted or reproduced.\"}]","KDOQI Clinical Practice Guideline Hemodialysis Update - Public Review Draft 2015 | PDF",1790335325,197]